India's preferred Personal finance destination
Home Shares News Centre F&O Mutual Funds IPO Portfolio Commodity Loans Financial Planning Insurance About Us
Markets Companies Research Industries E-Mail Page
Wealth Tracker      Tax Corner NRI Centre Chat Masala Feedback

my Last 5 Scrips
Company BSE Price(Rs) % Chg
State Ba 260.85 0.11
Reliance 1101.65 4.11
Tata Stl 553.60 0.19
Tata Mot 174.80 2.46
Cipla Lt 633.85 0.98
Clear All Clear Last
Equity
NSE Live
Nifty Live Prices
Live Quotes
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
BSE Live
BSE30 Live Prices
Live Quotes
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
Market Pulse
Leaders
Laggards
FII Activity
Mutual Fund Activity
Meetings
Results Watch
Results Calendar
Results Announced
IPO Watch
Company
Snapshots
Quotes
Charts
Financials
Recent News
Broker Research
Meetings
Research Tutorial
Discussion Forum
Research
Research Reports
News Watch
Sector Watch
Economy Watch
News-Glenmark Pharmaceutical Limited
Glenmark Pharmaceutical Limited
Sector:Pharmaceuticals Pharmaceuticals - Formulations
BSE:532296NSE:GLENMARKBloomberg:GNP@INReuters:GLEN.BO
Market Lot: 1Face Value: 1ISIN Demat: INE935A01035
QuotesSnapshotChartsFinancialsResearchRecent News
Peer GroupAGM/AMMF HoldingDiscussion ForumBSE/NSE NoticesBSE/NSE Deals

 
Corporate News
19-Oct-2018       Glenmark Pharma to present data on investigational treatment for Atopic Dermatitis IRIS
16-Oct-2018       Glenmark Pharma gets nod for Hydrocortisone Valerate cream IRIS
19-Sep-2018       Glenmark Pharma inducted into DJSI Emerging Market 2018 IRIS
17-Sep-2018       Glenmark Pharma gets USFDA approval for generic VAGIFEM IRIS
10-Sep-2018       Glenmark gets marketing authorization for generic Seretide Accuhaler IRIS
29-Aug-2018       Glenmark Pharma to sell generic spiriva inhaler in Western Europe IRIS
08-Aug-2018       Glenmark Pharma gets USFDA acceptance for new drug Ryaltris IRIS
06-Aug-2018       Glenmark Pharma, Harbour BioMed enter into license agreement IRIS
26-Jul-2018       Glenmark Pharma update on phase 1 study for GBR 310 IRIS
17-Jul-2018       Glenmark Pharma gets USFDA's nod for Colesevelam HCl IRIS
06-Jul-2018       Glenmark inks pact with Seqirus to commercialize Ryaltris IRIS
19-Jun-2018       Glenmark Pharma gets approval for North California facility IRIS
06-Jun-2018       Glenmark Pharma gets final approval for generic Loestrin IRIS
30-May-2018       Glenmark Pharm quarterly earnings fall 17.5%  IRIS
28-May-2018       Glenmark Pharma announces poster presentations on GBR 1302 and GBR 1342 IRIS
22-May-2018       Glenmark Pharma submits Ryaltris NDA application to USFDA IRIS
21-May-2018       Glenmark Pharma gets nod for Colesevelam HCl tablets IRIS
18-May-2018       Glenmark Pharmaceuticals updates on clinical study of GBR 830 IRIS
16-May-2018       Glenmark to introduce generic Seretide Accuhaler in Denmark IRIS
11-May-2018       Glenmark Pharma receives nod for Clobetasol propionate cream IRIS

 

 


Home | Shares | F&O | Mutual Funds | Loans | Insurance | News Centre
Wealth Tracker | Tax Corner | NRI Centre | Search in myiris | Advertise
All rights reserved. IRIS Business Services Limited
Disclaimer